Sean Lavin
Stock Analyst at BTIG
(1.94)
# 1,677
Out of 4,424 analysts
28
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
15 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Downgrades: Neutral | n/a | $75.75 | - | 1 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $177.53 | +80.25% | 4 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $82.76 | - | 1 | Jan 10, 2022 | |
| MASI Masimo | Downgrades: Neutral | n/a | $124.16 | - | 2 | Apr 16, 2019 | |
| HSDT Helius Medical Technologies | Downgrades: Neutral | n/a | $1.70 | - | 3 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | n/a | $99.88 | - | 2 | Apr 3, 2019 | |
| ATRC AtriCure | Upgrades: Buy | n/a | $22.00 | - | 2 | Apr 2, 2019 | |
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $14.05 | - | 3 | Jun 4, 2018 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $15.50 | - | 3 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $54.15 | - | 2 | Apr 3, 2018 | |
| ABT Abbott Laboratories | Downgrades: Neutral | n/a | $104.67 | - | 1 | Jan 22, 2018 | |
| AXDX Accelerate Diagnostics | Downgrades: Neutral | n/a | $0.87 | - | 1 | Dec 13, 2017 | |
| BSX Boston Scientific | Upgrades: Buy | n/a | $74.10 | - | 1 | Nov 30, 2017 | |
| DXCM DexCom | Downgrades: Neutral | n/a | $128.14 | - | 1 | May 3, 2017 | |
| EW Edwards Lifesciences | Downgrades: Neutral | n/a | $87.42 | - | 1 | Feb 2, 2017 |
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $75.75
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $177.53
Upside: +80.25%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $82.76
Upside: -
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $124.16
Upside: -
Helius Medical Technologies
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $1.70
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: n/a
Current: $99.88
Upside: -
AtriCure
Apr 2, 2019
Upgrades: Buy
Price Target: n/a
Current: $22.00
Upside: -
Tactile Systems Technology
Jun 4, 2018
Downgrades: Neutral
Price Target: n/a
Current: $14.05
Upside: -
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $15.50
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $54.15
Upside: -
Abbott Laboratories
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $104.67
Upside: -
Accelerate Diagnostics
Dec 13, 2017
Downgrades: Neutral
Price Target: n/a
Current: $0.87
Upside: -
Boston Scientific
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $74.10
Upside: -
DexCom
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $128.14
Upside: -
Edwards Lifesciences
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $87.42
Upside: -